Cyberounds Logo
August 03, 2020 | LOGIN | REGISTER | HELP | 

email a friend print Bookmark and Share
Memory and EAA Receptors
CME credit is no longer available for this conference.
Howard Eichenbaum, Ph.D.

Dr. Eichenbaum is at the Center for Memory and Brain, Boston University.

Dr. Eichenbaum has been a consultant to Saegis Pharmaceuticals within the past three years.

This activity is made possible by an unrestricted educational grant from Forest Laboratories.

Release Date: 01/06/2004
Termination Date: 01/06/2007

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Describe the physiological requirements for long-term potentiation and long-term depression
  • Describe the cellular mechanisms by which glutamate mediates long-lasting synaptic plasticity
  • Describe how AMPA and NMDA receptors contribute to memory.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity